Eli Lilly and Company ($LLY) Insider Trading & Smart Money Activity
Eli Lilly and Company ($LLY) has 4 insider trades, 8 congress trades, 59 13F position changes and 8 analyst ratings on file. Insiders filed 4 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 7
- 13F moves on file
- 59
- Analyst ratings on file
- 8
LLY insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 1 | 0 / 0 |
| Q2 2026 | 0 | 0 | 1 / 0 | 12 / 14 |
| Q3 2026 | 0 | 0 | 0 / 2 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 22 / 10 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All LLY insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | TD Waterhouse Canada | Added | +50.98K sh | $280.10M | — | ||||||
| 13F | TCV Trust & Wealth Management | Reduced | -509 sh | $26.11M | — | ||||||
| 13F | Saratoga Research & Investment Management | Reduced | -2.07K sh | $59.92M | — | ||||||
| 13F | RKL Wealth Management | Added | +1.14K sh | $4.07M | — | ||||||
| 13F | McKinley Carter Wealth Services | Added | +731 sh | $14.22M | — | ||||||
| 13F | Goelzer Investment Management | Added | +18.69K sh | $643.54M | — | ||||||
| 13F | Gemmer Asset Management | Added | +402 sh | $1.83M | — | ||||||
| 13F | Forbes J M | Added | +3.09K sh | $17.22M | — | ||||||
| 13F | Financial Synergies Wealth Advisors | Added | +105 sh | $384.25K | — | ||||||
| 13F | Elser Financial Planning | Added | +252 sh | $22.28M | — | ||||||
| 13F | Cyndeo Wealth Partners | Reduced | -2.33K sh | $18.05M | — | ||||||
| 13F | Concurrent Investment Advisors | Added | +17.06K sh | $73.93M | — | ||||||
| 13F | Banque Pictet & Cie | Reduced | -5.76K sh | $70.97M | — | ||||||
| 13F | Annex Advisory Services | Added | +29.35K sh | $38.39M | Read | ||||||
| 13F | Zwj Investment Counsel | Added | +3.31K sh | $11.57M | — | ||||||
| 13F | V-Square Quantitative Management | Added | +1.54K sh | $21.44M | — | ||||||
| 13F | Turtle Creek Wealth Advisors | Added | +822 sh | $33.14M | — | ||||||
| 13F | Ninety One UK | Reduced | -225.44K sh | $399.16M | Read | ||||||
| 13F | Ninety One SA (Pty) | Reduced | -855 sh | $15.06M | — | ||||||
| 13F | Guyasuta Investment Advisors | Added | +9.24K sh | $13.67M | — | ||||||
| 13F | Formuepleje A/S | Reduced | -1K sh | $4.21M | — | ||||||
| 13F | Fjarde Ap-Fonden /Fourth Swedish National Pension Fund | Reduced | -19.25K sh | $295.26M | — | ||||||
| 13F | First Merchants | Added | +2.69K sh | $61.46M | — | ||||||
| 13F | Atria Investments | Added | +5.49K sh | $45.83M | — | ||||||
| 13F | Assenagon Asset Management S.A. | Added | +283.91K sh | $908.23M | Read | ||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $1,500 | Read | |||||||
| Analyst | Cantor Fitzgerald | Reiterates to Overweight | PT $1,440 | +7.0% | — | ||||||
| Analyst | Morgan Stanley | Reiterates to Overweight | PT $1,430 | +1.7% | — | ||||||
| Analyst | JP Morgan | Reiterates to Overweight | PT $1,500 | -3.5% | — | ||||||
| Analyst | TD Cowen | Reiterates to Buy | PT $1,250 | +1.2% | — | ||||||
| Analyst | Guggenheim | Reiterates to Buy | PT $1,284 | +2.6% | — | ||||||
| Congress | Dan Newhouse | Sale | $1,001 - $15,000 | -0.8% | +3.6% | — | |||||
| Congress | Michael A. Rulli | Sale | $1,001 - $15,000 | +2.0% | -3.6% | — | |||||
| Analyst | Leerink Partners | Reiterates to buy | PT $1,232 | +7.6% | +6.2% | Read | |||||
| Insider | Gabrielle Sulzberger | Buy (Grant or award) | 4 sh | $4.52K | -2.4% | +2.4% | — | ||||
| Insider | Juan Luciano | Buy (Grant or award) | 14 sh | $15.81K | -2.4% | +2.4% | — | ||||
| Insider | Erik Fyrwald | Buy (Grant or award) | 9 sh | $10.16K | -2.4% | +2.4% | — | ||||
| Insider | Ralph Alvarez | Buy (Grant or award) | 11 sh | $12.42K | -2.4% | +2.4% | — | ||||
| Congress | Gilbert Ray Cisneros Jr. | Purchase | $50,001 - $100,000 | -2.1% | +4.6% | Read | |||||
| Analyst | Jefferies | Reiterates to buy | PT $1,350 | -1.9% | +6.3% | — | |||||
| Congress | Alan Armstrong | Sale | $1,001 - $15,000 | +5.6% | -1.1% | +35.2% | — | ||||
| Congress | Michael A. Rulli | Purchase | $1,001 - $15,000 | -1.6% | -3.4% | +11.5% | — | ||||
| Congress | Michael A. Rulli | Sale | $1,001 - $15,000 | — | |||||||
| Congress | John Boozman | Sale | $1,001 - $15,000 | — | |||||||
| Congress | Tommy Tuberville | Sale | $15,001 - $50,000 | — |
Showing 45 of 79 filings (the latest 13F moves are capped at 25; see the institutions below).
1W / 1M / 6M = how LLY moved from the trade or filing date.
Insider trading in LLY: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Gabrielle Sulzberger | 1 | — | Jun 15, 2026 | ||
| Juan Luciano | 1 | — | Jun 15, 2026 | ||
| Erik Fyrwald | 1 | — | Jun 15, 2026 | ||
| Ralph Alvarez | 1 | — | Jun 15, 2026 |
Members of Congress trading LLY
Institutions moving LLY (13F)
- Ninety One UK2
- Ifm Investors2
- TD Waterhouse Canada1
- TCV Trust & Wealth Management1
- Saratoga Research & Investment Management1
- RKL Wealth Management1
- McKinley Carter Wealth Services1
- Goelzer Investment Management1
- Gemmer Asset Management1
- Forbes J M1
- Financial Synergies Wealth Advisors1
- Elser Financial Planning1
Analyst ratings on LLY
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| RBC Capital | Reiterates | Outperform | $1,500 | Read | ||||
| Cantor Fitzgerald | Reiterates | Overweight | $1,410 → $1,440 | +7.0% | — | |||
| Morgan Stanley | Reiterates | Overweight | $1,419 → $1,430 | +1.7% | — | |||
| JP Morgan | Reiterates | Overweight | $1,400 → $1,500 | -3.5% | — | |||
| TD Cowen | Reiterates | Buy | $1,250 | +1.2% | — | |||
| Guggenheim | Reiterates | Buy | $1,273 → $1,284 | +2.6% | — | |||
| Leerink Partners | Reiterates | buy | $1,232 | +7.6% | +6.2% | Read | ||
| Jefferies | Reiterates | buy | $1,350 | -1.9% | +6.3% | — |
Frequently asked questions
What is the latest insider trade in LLY?
Gabrielle Sulzberger filed a buy (grant or award) of 4 sh worth $4.52K on Jun 15, 2026.
Which members of Congress traded LLY?
8 disclosed trades by Michael A. Rulli, Dan Newhouse, Gilbert Ray Cisneros Jr., Alan Armstrong and John Boozman. The latest was on Jul 10, 2026.
Which institutions changed their LLY positions?
Recent 13F filers moving the stock include Ninety One UK, Ifm Investors, TD Waterhouse Canada, TCV Trust & Wealth Management and Saratoga Research & Investment Management.
Other drug manufacturers - general stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.